AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $835,330 | -24.6% | 81,100 | +20.7% | 0.01% | -35.0% |
| Q2 2023 | $1,107,341 | +4.7% | 67,193 | -41.8% | 0.02% | 0.0% |
| Q1 2023 | $1,058,017 | +168.7% | 115,504 | +110.0% | 0.02% | +233.3% |
| Q4 2022 | $393,800 | -91.0% | 55,000 | -89.9% | 0.01% | -87.8% |
| Q4 2021 | $4,391,000 | -38.2% | 543,400 | -25.0% | 0.05% | -39.5% |
| Q3 2021 | $7,105,000 | +1424.7% | 725,000 | +947.8% | 0.08% | +1250.0% |
| Q2 2021 | $466,000 | -45.4% | 69,192 | -26.5% | 0.01% | -68.4% |
| Q1 2021 | $853,000 | +99.8% | 94,192 | +11.3% | 0.02% | +90.0% |
| Q3 2020 | $427,000 | +5.4% | 84,600 | +69.2% | 0.01% | -23.1% |
| Q2 2020 | $405,000 | -87.8% | 50,000 | -88.0% | 0.01% | -93.0% |
| Q1 2020 | $3,313,000 | – | 417,200 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |